You have 9 free searches left this month | for more free features.

Clinical remission

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Asthma Trial (Mepolizumab, Spirometry)

Not yet recruiting
  • Asthma
  • (no location specified)
Sep 15, 2023

Giant Cell Arteritis Trial (Secukinumab 300 mg, s.c., Placebo to match Secukinumab, s.c.)

Recruiting
  • Giant Cell Arteritis
  • Secukinumab 300 mg, s.c.
  • Placebo to match Secukinumab, s.c.
  • Berlin, Germany
  • +2 more
Oct 12, 2022

Ulcerative Colitis Trial in Naples (Filgotinib, Placebo)

Recruiting
  • Ulcerative Colitis
  • Naples, Florida
    Gastroenterology Group of Naples
Aug 2, 2022

Ulcerative Colitis Trial (Appendectomy, Infliximab)

Not yet recruiting
  • Ulcerative Colitis
  • (no location specified)
Jun 27, 2023

Diabetic Foot Trial in Madrid (2 weeks revision)

Not yet recruiting
  • Diabetic Foot
  • 2 weeks revision
  • Madrid, Spain
    Clínica Universitaria de Podología de la Universidad Complutense
Nov 15, 2023

Rheumatoid Arthritis, JAK Inhibitor, Musculoskeletal Ultrasound Trial in Nagasaki (upadacitinib 15mg/day)

Recruiting
  • Rheumatoid Arthritis
  • +3 more
  • upadacitinib 15mg/day
  • Nagasaki, Japan
    Nagasaki University Hospital
Nov 24, 2021

Severe Alcoholic Hepatitis Trial in New Delhi (Prednisolone, Standard Medical therapy, Placebo)

Not yet recruiting
  • Severe Alcoholic Hepatitis
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences (ILBS)
Dec 2, 2023

IBD Trial in Roma (Multimodal ultrasound)

Recruiting
  • Inflammatory Bowel Diseases
  • Multimodal ultrasound
  • Roma, Italy
    Fondazione Policlinico Gemelli IRCCS
Aug 3, 2023

ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)

Recruiting
  • ANCA-associated Vasculitis
  • Maintenance Therapy
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jul 20, 2023

Rectal Cancer Trial in Taipei (Surgery)

Recruiting
  • Rectal Cancer
  • Surgery
  • Taipei, Taiwan
    Jin-Tung LIANG
Jul 27, 2023

Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

Recruiting
  • Acute Myeloid Leukemia
  • Venclexta 100 MG Oral Tablet
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023

Giant Cell Arteritis Trial in Bonn (Methotrexate, Sodium chloride)

Recruiting
  • Giant Cell Arteritis
  • Bonn, Germany
    Medical Clinic and Polyclinic III Internal medicine Oncology, He
Dec 16, 2022

Residual Disease in Breast Cancer Remission After Primary

Recruiting
  • Breast Cancer
  • minimally invasive preoperative image-guided vacuum-assisted biopsy
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Jul 10, 2023

Colitis,Ulcerative Trial in Norway (Discontinuation of anti-TNF treatment, Continuation of anti-TNF treatment)

Active, not recruiting
  • Colitis,Ulcerative
  • Discontinuation of anti-TNF treatment
  • Continuation of anti-TNF treatment
  • Alesund, Norway
  • +18 more
Jul 13, 2022

Crohn Disease Trial in Liège (EXL01, Placebo, SoC corticosteroid - Induction Period)

Not yet recruiting
  • Crohn Disease
  • Liège, Belgium
    CHU de Liege
Sep 13, 2022

Diffuse Large B-cell Lymphoma (DLBCL) Trial in Lanzhou (Zanubrutinib)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • Lanzhou, Gansu, China
    The First Hospital of Lanzhou University
Oct 23, 2022

Diabetes, Type 2 Trial in Jönköping, Umeå, Örnsköldsvik (Total diet replacement, eHealth, Face-to-face)

Recruiting
  • Diabetes Mellitus, Type 2
  • Total diet replacement
  • +2 more
  • Jönköping, Sweden
  • +2 more
Aug 5, 2022

Diffuse Large B-cell Lymphoma Trial in Changchun (Mitoxantrone HCl liposome injection, RiTUXimab Injection, Cyclophosphamid)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • Mitoxantrone hydrochloride liposome injection
  • +4 more
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Aug 15, 2023

Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

Completed
  • Fallopian Tube Cancer
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 7, 2022

    Melanoma Trial in New York (DC Vaccine, Montanide Vaccine, Poly-ICLC)

    Completed
    • Melanoma
    • DC Vaccine
    • +2 more
    • New York, New York
    • +1 more
    Sep 13, 2022

    Progression Free Survival, Overall Survival, Maintenance Trial (Ixazomib DX/Lenalidomide DX)

    Not yet recruiting
    • Progression Free Survival
    • +2 more
    • Ixazomib DX/Lenalidomide DX
    • (no location specified)
    Jul 27, 2022

    Lupus Nephritis, Remission, Safety Issues Trial in Nanjing (Methylprednisolone Injectable Suspension, Belimumab Injection,

    Recruiting
    • Lupus Nephritis
    • +2 more
    • Methylprednisolone Injectable Suspension
    • +2 more
    • Nanjing, Jiangsu, China
      Jiong Zhang
    May 8, 2023

    Endoscopic Remission, Histologic Remission and Barrier Healing

    Recruiting
    • Inflammatory Bowel Diseases
    • Recording of major clinical events
    • Erlangen, Germany
      University Hospital Erlangen
    Dec 14, 2021

    Clinical Pathways for Newly Diagnosed Multiple Myeloma

    Not yet recruiting
    • Multiple Myeloma
    • Multiple Myeloma Without Mention of Remission
    • Multiple Myeloma Pathway
    • +2 more
    • (no location specified)
    Nov 27, 2023

    Type 2 Diabetes Trial in Umeå (Diabetes remission using total diet replacement and eHealth contact with the healthcare provider)

    Completed
    • Type 2 Diabetes
    • Diabetes remission using total diet replacement and eHealth contact with the healthcare provider
    • Umeå, Sweden
      Department of Public Health and Clinical Medicine, Medicine
    Jan 29, 2022